Marcaine Injection, Solution
Product Images NDC 0404-9770

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Marcaine (NDC 0404-9770). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Henry Schein, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Formula1.jpg (Formula1)

FDA Label Image

Formula2.jpg (Formula2)

FDA Label Image

Image1.jpg (Image1)

Image1.jpg (Image1)
This is a description of the types of blocks that can be performed using MARCAINE or MARCAINE WITH EPINEPHRINE, along with their recommended concentrations. The table includes information on various types of blocks such as local infiltration, peripheral nerve block, retrobulbar block, sympathetic block, caudal block, lumbar epidural block, epidural test dose, and dental block. It also specifies the recommended concentrations for each type of block. Additionally, it provides a note stating that MARCAINE 0.75% (7.5 mg/mL) is not recommended for nonobstetrical surgical procedures. It advises against the use of multiple-dose vials of MARCAINE and MARCAINE WITH EPINEPHRINE for caudal or epidural anesthesia.*
FDA Label Image

Image2.jpg (Image2)

Image2.jpg (Image2)
The provided text contains information about different concentrations of MARCAINE and MARCAINE WITH EPINEPHRINE, their effects on motor function, and recommended usage for various types of blocks and operations. The text outlines how each concentration affects motor function for caudal, epidural, or peripheral nerve blocks, emphasizing factors like speed of onset and completeness of muscle relaxation. It also specifies which concentration is most suitable for specific types of operations and anesthesia procedures. Additionally, it clarifies that there is no 0.75% concentration available for MARCAINE WITH EPINEPHRINE.*
FDA Label Image

Image3.jpg (Image3)

FDA Label Image

Image4.jpg (Image4)

Image4.jpg (Image4)
This is a text discussing different concentrations of local anesthetics for nerve blocks, including the effects of repeat doses on motor block. It mentions the potential for complete motor block with certain concentrations, especially when combined with epinephrine. The text also highlights the use of certain solutions for epidural technique and specifies their application for spinal surgeries. It concludes with instructions regarding the use of these anesthetics for single-dose and continuous techniques, particularly emphasizing the caution for obstetrical anesthesia.*
FDA Label Image

Image5.jpg (Image5)

Image5.jpg (Image5)
This is a list of drugs associated with methemoglobinemia, including nitrates/nitrites, local anesthetics, antineoplastic agents, antibiotics, antimalarials, anticonvulsants, and other drugs. Examples of these drugs include nitroglycerin, lidocaine, cyclophosphamide, nitrofurantoin, chloroquine, phenobarbital, and acetaminophen.*
FDA Label Image

Image6.jpg (Image6)

Image6.jpg (Image6)
This text provides information on various concentrations and packaging sizes for a medication, including single-dose and multiple-dose vials with different strengths ranging from 25 mg/10 mL to 125 mg/50 mL. The medication is available in trays and cartons, with concentrations of 0.25% and 0.5% described in the text.*
FDA Label Image

Image7.jpg (Image7)

Image7.jpg (Image7)
This text provides information on various medications with different concentrations and packaging sizes. It includes details such as NDC codes, percentages, and quantities of medicine in the single-dose vials and multiple-dose vials. The medications have different strengths, such as 150 mg/30 mL, 250 mg/50 mL, and 75 mg/10 mL. The text also mentions the packaging quantities, such as trays of 10 or 25 vials. This information is useful for healthcare professionals or pharmacists to understand the different options available for these medications.*
FDA Label Image

Image8.jpg (Image8)

Image8.jpg (Image8)
This text provides information about different pharmaceutical products containing varying concentrations of an active ingredient. The products are presented in single-dose vials or multiple-dose vials, with dosages ranging from 25 mg/ml to 5 mg/ml. The National Drug Codes (NDC) for each product are also listed for identification purposes.*
FDA Label Image

Label1.jpg (Label1)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.